BackClinuvel Pharmaceuticals Limited Overview

Clinuvel Pharmaceuticals Limited Profit Margin

Valuation check: CLVLF's profit margin is 38.11%, above the Healthcare sector average of 17.63%.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

28.28%
↓ 28.38% YoY

As of Dec 2025

Annual Profit Margin (TTM)

38.11%
↑ 2.20% YoY

Trailing 12 months ending Dec 2025

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Clinuvel Pharmaceuticals Limited (CLVLF) FAQ

Clinuvel Pharmaceuticals Limited posts a profit margin of 38.11% as of December 2025. That compares with 37.28% in the prior-year period — up 2.2% year over year. That is above the Healthcare sector average of 17.63%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Clinuvel Pharmaceuticals Limited's profit margin was 37.28%. The latest reading is 38.11% — a 2.2% year-over-year increase (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 17.63% is typical. Clinuvel Pharmaceuticals Limited's 38.11% is higher that level. That is roughly 116.2% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Clinuvel Pharmaceuticals Limited's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 38.11% as of December 2025; use YoY and peer views to separate noise from signal.

Context for CLVLF's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 17.63%), and (3) consistency with growth and profitability. This page covers the first two; Clinuvel Pharmaceuticals Limited's other metric pages and overview cover the third.